{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:52:01Z","timestamp":1757627521524,"version":"3.44.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2022A1515010673"],"award-info":[{"award-number":["2022A1515010673"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Science and Technology Research Foundation of Guangdong Province","award":["A2020621"],"award-info":[{"award-number":["A2020621"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14850-1","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T09:15:06Z","timestamp":1756804506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A subgroup analysis of locally advanced nasopharyngeal carcinoma patients with small lymph nodes and large nodes using adaptive radiotherapy"],"prefix":"10.1186","volume":"25","author":[{"given":"Wenyan","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peixun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyue","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongtai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yupeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongwen","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyue","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxue","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixiong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senkui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"issue":"10192","key":"14850_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64\u201380.","journal-title":"Lancet"},{"issue":"1","key":"14850_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-022-01307-2","volume":"15","author":"L Xu","year":"2022","unstructured":"Xu L, Zou C, Zhang S, Chu TSM, Zhang Y, Chen W, Zhao C, Yang L, Xu Z, Dong S, et al. Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors. J Hematol Oncol. 2022;15(1):87.","journal-title":"J Hematol Oncol."},{"issue":"1","key":"14850_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13014-020-01626-z","volume":"15","author":"P Bai","year":"2020","unstructured":"Bai P, Weng X, Quan K, Chen J, Dai Y, Xu Y, Lin F, Zhong J, Wu T, Chen C. A knowledge-based intensity-modulated radiation therapy treatment planning technique for locally advanced nasopharyngeal carcinoma radiotherapy. Radiat Oncol. 2020;15(1):188.","journal-title":"Radiat Oncol"},{"issue":"1","key":"14850_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/1748-717X-8-226","volume":"8","author":"X Niu","year":"2013","unstructured":"Niu X, Chang X, Gao Y, Hu C, Kong L. Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue. Radiat Oncol. 2013;8(1):226.","journal-title":"Radiat Oncol"},{"key":"14850_CR5","doi-asserted-by":"crossref","unstructured":"Sun XS, Li XY, Chen QY, Tang LQ, Mai HQ. Future of radiotherapy in nasopharyngeal carcinoma. Br J Radiol. 2019;92(1102):20190209.","DOI":"10.1259\/bjr.20190209"},{"issue":"3","key":"14850_CR6","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.21037\/qims-22-776","volume":"13","author":"D Yan","year":"2023","unstructured":"Yan D, Yin X, Wang L, Huang L, Tang Q, Cheng K, Yan S. Induction chemotherapy reduces target volume drift in patients with locoregionally advanced nasopharyngeal carcinoma undergoing adaptive intensity-modulated radiotherapy: A retrospective cohort study. Quant Imaging Med Surg. 2023;13(3):1779\u201391.","journal-title":"Quant Imaging Med Surg"},{"key":"14850_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.oraloncology.2018.08.010","volume":"86","author":"MF Gensheimer","year":"2018","unstructured":"Gensheimer MF, Le Q-T. Adaptive radiotherapy for head and neck cancer: are we ready to put it into routine clinical practice? Oral Oncol. 2018;86:19\u201324.","journal-title":"Oral Oncol"},{"issue":"3","key":"14850_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.semradonc.2019.02.007","volume":"29","author":"JJ Sonke","year":"2019","unstructured":"Sonke JJ, Aznar M, Rasch C. Adaptive radiotherapy for anatomical changes. Semin Radiat Oncol. 2019;29(3):245\u201357.","journal-title":"Semin Radiat Oncol"},{"key":"14850_CR9","doi-asserted-by":"publisher","first-page":"792024","DOI":"10.3389\/fonc.2021.792024","volume":"11","author":"SK Lam","year":"2022","unstructured":"Lam SK, Zhang Y, Zhang J, Li B, Sun JC, Liu CYT, Chou PH, Teng X, Ma ZR, Ni RY, et al. Multi-organ omics-based prediction for adaptive radiation therapy eligibility in nasopharyngeal carcinoma patients undergoing concurrent chemoradiotherapy. Front Oncol. 2022;11:792024.","journal-title":"Front Oncol"},{"issue":"1","key":"14850_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/jrr\/rrt076","volume":"55","author":"J Lu","year":"2013","unstructured":"Lu J, Ma Y, Chen J, Wang L, Zhang G, Zhao M, Yin Y. Assessment of anatomical and dosimetric changes by a deformable registration method during the course of intensity-modulated radiotherapy for nasopharyngeal carcinoma. J Radiat Res. 2013;55(1):97\u2013104.","journal-title":"J Radiat Res"},{"issue":"2","key":"14850_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.meddos.2011.08.003","volume":"37","author":"H Yang","year":"2012","unstructured":"Yang H, Hu W, Ding W, Shan G, Wang W, Yu C, Wang B, Shao M, Wang J, Yang W. Changes of the transverse diameter and volume and dosimetry before the 25th fraction during the course of intensity-modulated radiation therapy (IMRT) for patients with nasopharyngeal carcinoma. Med Dosim. 2012;37(2):225\u20139.","journal-title":"Med Dosim"},{"issue":"3","key":"14850_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.radonc.2012.03.013","volume":"104","author":"HCY Cheng","year":"2012","unstructured":"Cheng HCY, Wu VWC, Ngan RKC, Tang KW, Chan CCL, Wong KH, Au SK, Kwong DLW. A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients. Radiother Oncol. 2012;104(3):317\u201323.","journal-title":"Radiother Oncol"},{"issue":"5","key":"14850_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.bulcan.2019.12.013","volume":"107","author":"D Hend","year":"2020","unstructured":"Hend D, Mnejja W, Fourati N, Kallel M, Siala W, Sahnoun T, Farhat L, Daoud J. La radioth\u00e9rapie adaptative des carcinomes nasopharyng\u00e9s: O\u00f9 sommes-nous ? Bull Cancer. 2020;107(5):565\u201373.","journal-title":"Bull Cancer"},{"issue":"2","key":"14850_CR14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jmir.2023.02.005","volume":"54","author":"A Chophy","year":"2023","unstructured":"Chophy A, Gupta S, Singh P, Sharma N, Krishnan AS, Namitha RS, Roushan R, Rastogi A, Nair S, Diundi A, et al. Evaluation of dosimetric and volumetric changes in target volumes and organs at risk during adaptive radiotherapy in head and neck cancer: A prospective study. J Med Imaging Radiat Sci. 2023;54(2):306\u201311.","journal-title":"J Med Imaging Radiat Sci"},{"issue":"2","key":"14850_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ijrobp.2009.08.036","volume":"77","author":"W Wang","year":"2010","unstructured":"Wang W, Yang H, Hu W, Shan G, Ding W, Yu C, Wang B, Wang X, Xu Q. Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2010;77(2):617\u201321.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"14850_CR16","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11604-013-0225-5","volume":"31","author":"C Chen","year":"2013","unstructured":"Chen C, Lin X, Pan J, Fei Z, Chen L, Bai P. Is it necessary to repeat CT imaging and replanning during the course of intensity-modulated radiation therapy for locoregionally advanced nasopharyngeal carcinoma? Jpn J Radiol. 2013;31(9):593\u20139.","journal-title":"Jpn J Radiol"},{"issue":"4","key":"14850_CR17","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.canrad.2021.08.023","volume":"26","author":"R Avgousti","year":"2022","unstructured":"Avgousti R, Antypas C, Armpilia C, Simopoulou F, Liakouli Z, Karaiskos P, Kouloulias V, Kyrodimos E, Moulopoulos LA, Zygogianni A. Adaptive radiation therapy: when, how and what are the benefits that literature provides? Cancer\/Radioth\u00e9rapie. 2022;26(4):622\u201336.","journal-title":"Cancer\/Radioth\u00e9rapie"},{"issue":"1","key":"14850_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4103\/jcrt.JCRT_350_20","volume":"17","author":"V Nautiyal","year":"2021","unstructured":"Nautiyal V, Kumar V, Kant R, Gupta M, Bansal S, Ahmad M. Study of volumetric and dosimetric changes during fractionated radiotherapy in head and neck cancers: A single centre experience. J Cancer Res Ther. 2021;17(1):235\u201341.","journal-title":"J Cancer Res Ther."},{"issue":"22","key":"14850_CR19","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","volume":"27","author":"N Lee","year":"2009","unstructured":"Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, Bosch W, Morrison WH, Quivey J, Thorstad W, et al. Intensity-Modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009;27(22):3684\u201390.","journal-title":"J Clin Oncol"},{"issue":"18","key":"14850_CR20","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.7150\/jca.20351","volume":"8","author":"S-B Liang","year":"2017","unstructured":"Liang S-B, Wang Y, Hu X-F, He S-S, Yang X-L, Liu L-Z, Cui C-Y, Chen Y, Fu L-W. Survival and toxicities of IMRT based on the RTOG protocols in patients with nasopharyngeal carcinoma from the endemic regions of China. J Cancer. 2017;8(18):3718\u201324.","journal-title":"J Cancer"},{"issue":"3","key":"14850_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/jrr\/rru119","volume":"56","author":"I Chitapanarux","year":"2015","unstructured":"Chitapanarux I, Chomprasert K, Nobnaop W, Wanwilairat S, Tharavichitkul E, Jakrabhandu S, Onchan W, Traisathit P, Van Gestel D. A dosimetric comparison of two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal cancer. J Radiat Res. 2015;56(3):529\u201338.","journal-title":"J Radiat Res"},{"issue":"2","key":"14850_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.semradonc.2009.11.002","volume":"20","author":"P Castadot","year":"2010","unstructured":"Castadot P, Lee JA, Geets X, Gr\u00e9goire V. Adaptive radiotherapy of head and neck cancer. Semin Radiat Oncol. 2010;20(2):84\u201393.","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"14850_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13014-014-0318-z","volume":"10","author":"J Castelli","year":"2015","unstructured":"Castelli J, Simon A, Louvel G, Henry O, Chajon E, Nassef M, Haigron P, Cazoulat G, Ospina JD, Jegoux F, et al. Impact of head and neck cancer adaptive radiotherapy to spare the Parotid glands and decrease the risk of Xerostomia. Radiat Oncol. 2015;10(1):6.","journal-title":"Radiat Oncol."},{"issue":"1","key":"14850_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-015-0498-1","volume":"10","author":"H Huang","year":"2015","unstructured":"Huang H, Lu H, Feng G, Jiang H, Chen J, Cheng J, Pang Q, Lu Z, Gu J, Peng L, et al. Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy. Radiat Oncol. 2015;10(1):1\u20139.","journal-title":"Radiat Oncol"},{"issue":"3","key":"14850_CR25","doi-asserted-by":"publisher","first-page":"S489","DOI":"10.1016\/j.ijrobp.2012.07.1300","volume":"84","author":"X Peng","year":"2012","unstructured":"Peng X, Jinyi L, Weidong W. Clinical study of the necessity of multiple replanning during the course of intensity modulated radiation therapy for patients with locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2012;84(3):S489\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"14850_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.meddos.2019.05.003","volume":"45","author":"Z Stauch","year":"2020","unstructured":"Stauch Z, Zoller W, Tedrick K, Walston S, Christ D, Hunzeker A, Lenards N, Culp L, Gamez ME, Blakaj D. An evaluation of adaptive planning by assessing the dosimetric impact of weight loss throughout the course of radiotherapy in bilateral treatment of head and neck cancer patients. Med Dosim. 2020;45(1):52\u20139.","journal-title":"Med Dosim"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14850-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14850-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14850-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:11:29Z","timestamp":1757477489000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14850-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14850"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14850-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Institutional Review Board of Sun Yat-Sen University Cancer Center (SL-B2023-498-01) in accordance with the Declaration of Helsinki. Written informed consent was obtained from all individual patients included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1414"}}